Samjo Capital LLC Exagen Inc. Transaction History

Samjo Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$8.97 - $14.08 $2.65 Million - $4.15 Million	-295,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$10.25 - $15.21 $922,500 - $1.37 Million	90,000 Added 43.9%	295,000 $4.01 Million
Q2 2021 Aug 13, 2021	BUY	$12.4 - $17.92 $682,000 - $985,600	55,000 Added 36.67%	205,000 $3.07 Million
Q1 2021 May 12, 2021	BUY	$13.9 - $22.0 $2.09 Million - $3.3 Million	150,000 New	150,000 $2.63 Million

6.29M

2.5K

200

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $50.2M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Samjo Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Samjo Capital LLC with notifications on news.